TIALD and hepatocellular carcinoma: Taken together, we identified a novel m6A-mediated lncRNA, TIALD, which is the first lncRNA shown to be involved in the regulation of AURKA lysosomal degradation, links the function of METTL16 induced m6A modification on promoting HCC metastasis.